title: A prospective study of mother-to-infant HIV transmission in tribal women from India.
abstract: The transmission of human immunodeficiency virus type 1 from infected mothers to their babies was assessed by serologic, virologic, and clinical means. Of the 160 antibody-positive women enrolled at the beginning of the study, 13 had overt clinical symptoms (CDC stage III/IV). Termination of pregnancy was done, on request, in seven of these cases. The rest delivered prematurely. A total of 143 parturient women and their infants were followed prospectively until the babies were 18 months of age. Fifteen infants (9%) died of AIDS before 14 months of age. The remaining 128 children (91%) were alive at the end of the study period. Seventy-four seropositive children (46%) became seronegative and were considered noninfected. None of the seronegative children reverted to seropositive status despite the fact that they were breast-fed. The majority of the seropositive children (63%) became symptomatic and clinically ill during infancy. The overall mother-to-infant vertical transmission rate was 48%.
authors.affiliation: Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, UAE University, Al Ain.
authors.forename: R M
authors.initials: RM
authors.lastname: Kumar
authors.forename: S A
authors.initials: SA
authors.lastname: Uduman
authors.forename: A K
authors.initials: AK
authors.lastname: Khurranna
mesh_terms: D000328:Adult; D005006:Ethnicity; D005260:Female; D005500:Follow-Up Studies; D015483:HIV Antibodies / Q000032:analysis; D016655:HIV Core Protein p24 / Q000032:analysis; D015658:HIV Infections / Q000175:diagnosis / Q000401:mortality / Q000635:transmission*; D006679:HIV Seropositivity / Q000175:diagnosis; D015497:HIV-1 / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D010920:Placenta / Q000821:virology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000453:epidemiology*; D011446:Prospective Studies; D014776:Virus Cultivation
chemical_list: D015483:HIV Antibodies; D016655:HIV Core Protein p24